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Abstract
The human APOBEC3G (A3G) protein is a cellular polynucleotide cytidine deaminase that acts as a host restriction factor of
retroviruses, including HIV-1 and various transposable elements. Recently, three NMR and two crystal structures of the
catalytic deaminase domain of A3G have been reported, but these are in disagreement over the conformation of a terminal
b-strand, b2, as well as the identification of a putative DNA binding site. We here report molecular dynamics simulations
with all of the solved A3G catalytic domain structures, taking into account solubility enhancing mutations that were
introduced during derivation of three out of the five structures. In the course of these simulations, we observed a general
trend towards increased definition of the b2 strand for those structures that have a distorted starting conformation of b2.
Solvent density maps around the protein as calculated from MD simulations indicated that this distortion is dependent on
preferential hydration of residues within the b2 strand. We also demonstrate that the identification of a pre-defined DNA
binding site is prevented by the inherent flexibility of loops that determine access to the deaminase catalytic core. We
discuss the implications of our analyses for the as yet unresolved structure of the full-length A3G protein and its biological
functions with regard to hypermutation of DNA.
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Introduction
The human APOBEC3G protein (A3G) is a cellular polynu-
cleotide cytidine deaminase that can restrict the spread of HIV-1
in the absence of the viral Vif protein [1]. HIV-1 Vif specifically
interacts with A3G and targets it for proteasomal degradation,
thereby lifting the barrier that A3G poses to virus replication [2,3].
In the absence of Vif-mediated down-regulation, A3G is packaged
into assembling virions where it interferes with the elongation of
reverse transcription and catalyses deamination of cytidine to
uridine in nascent reverse transcripts [4–9]. This causes the
progeny viruses that have been exposed to A3G to lose infectivity
by virtue of halted reverse transcription and the loss of genomic
integrity. In addition to its activity as an HIV-1 restriction factor,
A3G as well as other APOBEC proteins can inhibit the spread of
several other viruses and transposable elements [10].
The APOBEC3G protein contains two cytidine deaminase
(CDA) domains, termed the N-terminal and C-terminal CDAs (N-
CDA and C-CDA, respectively). The CDA domains of all
APOBEC3 (A3) proteins are predicted to fold into a mixed five-
stranded b-sheet that exposes on one face two a-helices that
contain the H/C-X-E-X23-28-P-C-X2-C zinc coordination motif
[11]. This zinc-coordination motif is essential for catalysis of the
deamination reaction, yet not all the zinc-coordination motifs
encountered in A3 proteins constitute an active deaminase
catalytic core. In particular, the N-CDA of A3G is catalytically
inactive but is required for virus inhibition by mediating RNA-
dependent oligomerisation and packaging into virions [12–17].
Conversely, cytidine deamination is strictly mediated by the C-
CDA of A3G [10,18–20].
The deamination activity of A3 proteins is also commonly
referred to as DNA editing, in reference to the founding member
of the APOBEC protein family, APOBEC1 (A1), which is an
RNA-editing enzyme [21,22]. Unlike A1, A3G is unable to edit
RNA and its editing activity is tightly restricted to single stranded
DNA substrates. A3G preferentially edits the third cytidine in a 59-
CCC-39 trinucleotide sequence context on single stranded DNA,
whereas it is unable to edit double stranded DNA or DNA/RNA
hybrids [6,23,24]. The selective editing of single stranded DNA is
a shared property of A3 proteins, although differences in target site
preferences do exist. For example, APOBEC3F (A3F), another
member of the A3 family that restricts HIV-1 in the absence of
Vif, preferentially edits in a 59-TTC-39 sequence context [25–27].
Although structural data on the full length A3G protein are
currently lacking, several recent studies have reported high-
resolution structures of truncated A3G constructs containing the
PLoS ONE | www.plosone.org 1 July 2010 | Volume 5 | Issue 7 | e11515catalytic C-CDA moiety of A3G (table 1). First, Chen et al.
reported the solution structure of a 187 amino acid fragment by
NMR, encompassing amino acids 198 up to 384 of A3G, which
contained 5 mutations that were introduced to enhance the
solubility of the protein (PDB code 2JYW) [28]. Second, Holden
et al. obtained crystals that diffracted to a resolution of 2.3 A ˚ with
a 184 amino acid fragment, encompassing amino acids 197 up to
380 of A3G with the wild type sequence (PDB codes 3E1U and
3IQS) [29]. Third, Furakawa et al. reported the NMR structure of
a 192 amino acid fragment, encompassing amino acids 193 up to
384 of A3G, also with the wild type sequence (PDB code 2KBO)
[30]. Fourth, Harjes et al. reported an NMR structure of a 194
amino acid fragment encompassing residues 191 up to 384, which
also contained the five solubility enhancing point mutations (PDB
code 2KEM) [31]. Finally, a crystal structure of the 191–384
fragment containing the solubility enhancing mutations at a
resolution of 2.25 A ˚ has been reported most recently (PDB code
3IR2) [32]. For clarity, the original references and accession codes
are shown in table 1, along with the nomenclature we will adopt
from this point on.
Throughout these studies most of the core secondary structure
elements that characterise APOBEC proteins, as first reported in
the crystal structure of human APOBEC2 (A2)[33], were
preserved. However, a number of differences between these
structures are also apparent. Most strikingly, a b-strand at the edge
of the mixed sheet, termed b2, is predominantly disordered and
discontinuous in all NMR structures, regardless of the presence or
absence of the solubility enhancing mutations (Figure 1). The b2-
strand is much more defined through interactions with the b1
strand in the crystal structure with the wild type sequence,
XRAY1, although even in this structure a small distortion from
regular b-sheet geometry is apparent due to the bulging out of a
single amino acid, Q237. The b2-strand from the crystal structure
with mutations, XRAY2-2K3A, is also considerably more defined
than in the NMR structures, but in this case the bulge contains
amino acids N236, Q237, R238 and R239 (Figure 1).
The conformation of the b2 strand has important implications
for the folding of the full length A3G protein [12,34]. The full-
length A3G polypeptide consists of two CDA domains, but it
remains unknown how these domains are positioned relative to
each other. We and others have previously proposed homology
models of A3G in which the N- and C-terminal CDA domains are
aligned via interactions involving b2 to form a continuous b-sheet
as observed in the crystal structure of the closely related A2 protein
[12,16,35]. This continuous sheet would be consistent with the
conformation of b2 as observed in the first crystal structure of the
A3G C-CDA, but the distorted b2 observed in the NMR
structures and the second crystal structure may interfere with this
arrangement (Figure S1).
There is also disagreement with regard to the assignment of
residues within the A3G C-CDA that participate in interactions
with the substrate DNA. To date, no structure of the A3G protein
bound to DNA has been obtained and the identification of
residues that interact with the substrate has therefore relied on
indirect methods. Importantly, DNA-binding grooves proposed on
the basis of the wild-type crystal structure [29] and the first
reported NMR structure with mutations [28] have entirely
different orientations [34]. Furthermore, empirical identification
of amino acids that interact with the DNA by chemical shift
perturbations in response to DNA titrations have yielded
significantly different sets of candidate residues in two NMR
studies [28,30]. Positioning of loops in the vicinity of the catalytic
core also differs significantly in all of these structures (Figure 1),
with the two crystal structures sharing the highest overall similarity
(table 2 and Figure 1F).
We note that the differences between the two crystal structures
appear to be mostly due to different crystal packing interactions. In
the XRAY1 crystal, the C-CDA is clearly observed as monomeric
within the unit cell [29], whereas the unit cells of the XRAY2-
2K3A crystal contain dimers of the C-CDA [32]. Most of the
solubility enhancing mutations present in XRAY2-2K3A are in
close proximity to the multimer interfaces observed in that crystal
(not shown), suggesting that these mutations may have affected the
crystal packing. Although it has been suggested that the A3G C-
CDA has the capacity to oligomerise [36], none of the interfaces
observed in the XRAY2-2K3A crystal have been demonstrated to
be of significance for biological activities [32]. The monomeric
state of the A3G C-CDA as observed in the XRAY1 structure is
furthermore supported by ultracentrifugation analyses that were
performed on the NMR1-2K3A preparation [28].
Molecular dynamics (MD) simulations are a computational
means to probe molecular motions at an atomic scale and provide
the opportunity to monitor dynamical features of protein
structures that are not readily obtainable from crystallography
and NMR data. Here, we report MD simulations of each of the
available high-resolution structures of the A3G C-CDA domain.
The data sets from the MD simulations were specifically analysed
to shed light on the uncertainties regarding the possible
conformations of b2, as well as assignment of the DNA binding
site.
Results
Antiviral and editing properties of A3G with solubility-
enhancing mutations
Because the structures reported by Chen, Harjes and Shandila
all contain five mutations to enhance solubility of the protein
[28,31,32], we first sought to determine whether these mutations
alter the biological properties of A3G. Specifically, the truncated
A3G constructs used in those NMR and crystallography studies
contained the following mutations, which are collectively known
as 2K3A: L234K, C243A, F310K, C321A and C356A (Figure
S2). We assessed the effect of these mutations on antiviral activity
and DNA editing, both individually and in combination. Because
the L234K and C243A mutations are both located within b2t h a t
appears distorted in these structures, we also constructed a
mutant A3G containing both these mutations. We note that
Harjes et al. already reported normal antiviral activity of full
Table 1. Nomenclature of APOBEC structures used in this
study with references.
Nomenclature PDB code Reference
NMR1-2K3A 2JYW Chen K.M., et al. Nature (2008) 452:116–9
NMR2 2KBO Furukawa A., et al. EMBO J. (2009) 28:440–51
NMR3-2K3A 2KEM Harjes E., et al. J Mol Biol (2009) 389:819–32
XRAY1 3E1U*/3IQS Holden L.G., et al. Nature (2008) 456:121–4
XRAY2-2K3A 3IR2 Shandilya S.M.D. et al. Structure (2010) 18:28–38
A2 2NYT Prochnow C., et al Nature (2007) 445: 447–451
*The crystal structure originally deposited as 3E1U was found to contain an
error with regard to fitting of residue W269 to the electron density. This was
corrected in the structure deposited as 3IQS. The positioning of W269 in 3E1U
and 3IQS does not affect the conformation of b2 or the proposed DNA binding
pocket. MD simulations described here were performed with 3E1U.
doi:10.1371/journal.pone.0011515.t001
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terminally GFP-tagged A3G. Because we have previously
observed that a GFP-tag on A3G can reverse the effect of
mutations that cause reduced protein expression (Huthoff,
unpublished results), we performed our mutational analysis with
untagged full-length A3G. Single cycle infectivity experiments
confirmed that inhibition of Vif-deficient HIV-1 by A3G was
maintained in the presence of these mutations and that all
proteins were expressed in similar amounts as determined by
immunoblotting (Figure 2A).
We next assessed the DNA editing properties of the wild type
and mutant A3G using a bacterial mutator assay [37]. Again,
DNA editing by these mutant A3G proteins has previously been
reported in the context of 191–384 and 198–384 truncated
constructs [28,31], but not in the context of the full-length protein.
We observed wild-type levels of DNA editing with all constructs
except the 2K3A-A3G, which displayed DNA editing activity that
was approximately 2-fold higher than the wild type A3G
(Figure 2B). These observations are entirely consistent with the
previously reported studies with tagged or truncated A3G [28,31],
and indicate that A3G containing the solubility enhancing
mutations maintained virus inhibition and DNA editing activities
in the context of the full-length protein.
The b2 region of the A3G C-CDA contains an insert of
two amino acids
The distorted conformation of the b2 that is observed in the
majority of A3G C-CDA structures represents a unique feature
among CDA enzymes, as all other structures of these proteins
show a defined and continuous b2 strand [34]. Indeed, the
structure of the closely related A2 protein also shows an intact b2
region that is continuous with b1 and furthermore supports
oligomerisation via b2-b2 interactions [33]. To determine whether
this difference may be due to divergent primary sequences, we
generated an alignment of the b1-b2 region from A2 and the
human A3 proteins, indicating the b1-b2 interactions observed in
the crystal structures of A2 and the various structures of the A3G
C-CDA (Figure 3). From the alignment, it is apparent that the
sequence of the b1 region contains a strongly conserved L-C-F/Y
Figure 1. Ribbon representation of high-resolution structures of the A3G C-CDA. (A) Structure of NMR1-2K3A shown in green. (B) Structure
of NMR2 shown in red. (C) Structure NMR3-2K3A shown in blue. (D) Structure of XRAY1 shown in purple. (E) Structure of XRAY2-2K3A shown in
yellow. (F) Superimposition of XRAY1 and XRAY2-2K3A. The colour coding is maintained throughout. Details of these structures are described in the
text and the original references as well as the nomenclature adopted here are given in table 1. b-strands are numbered 1 through 5 and a-helices are
numbered a1 through a6.
doi:10.1371/journal.pone.0011515.g001
Table 2. RMSD of Ca atoms for the reported high-resolution
structures of the A3G C-CDA.
NMR1-
2K3A NMR2
NMR3-
2K3A XRAY1
XRAY2-
2K3A
NMR1-2K3A 0
NMR2 2.985 0
NMR3-2K3A 4.689 4.220 0
XRAY1 4.621 4.348 3.017 0
XRAY2-2K3A 4.726 4.228 3.004 1.814 0
doi:10.1371/journal.pone.0011515.t002
MD Simulations of APOBEC3G
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the b2 region of A2. The latter motif is partly conserved in the
human A3 proteins, and in A3G corresponds to G-F-L at positions
240 to 242. Importantly, the interaction between these motifs is
evidenced by both crystal structures and is to variable extents also
evident from the NMR data (Figure 3).
Throughout the remainder of the b1-b2 region, significant
differences in the sequence between A2 and the A3 proteins arise,
which in the case of A3A, A3B C-CDA and the A3G C-CDA
includes a two-amino acid insert. It is in the direct vicinity of this
insert, which in A3G corresponds to N236 and Q237, that
differences between the H-bonding in the b1-b2 region of the A3G
C-CDA crystal structures are observed. Importantly, these define
the distortion of the b2 strand in the A3G C-CDA NMR
structures and the crystal structure XRAY2-2K3A. In the XRAY1
structure with the most regular b2 geometry, residues V224, R226
and H228 are H-bonded to R238, Q237, L235 and V233,
respectively (V224 interacting with both R238 and Q237). The
bulged-out conformation of b2 that is observed in the XRAY2-
2K3A structure coincides with H-bonding of residues V224, R226
and H228 to L235, V233 and T231, respectively. Variations on
this latter arrangement are observed in each of the NMR
structures, which are also characterised by a bulged out
conformation of the b2 strand. Thus, multiple registers of H-
bonding with the b2 of the A3G-CDA are possible and can cause
this strand to be more or less structured.
Figure 2. Virus inhibition and DNA editing by A3G with and without solubility-enhancing mutations. (A) Single-cycle infectivity of HIV-
1/Dvif viruses produced in the presence of wild type or mutant A3G measured in b-Galactosidase units (RGU) and presented as percent infectivity
relative to the sample without A3G. Expression of wild type and mutant A3G proteins in 293T producer cells as determined by immunoblotting is
shown beneath the graph. (B) Relative editing activity of wild type and mutant A3G proteins from 12 independent experiments. Immunoblots
beneath the graph show the expression of A3G in equal volumes of bacterial cultures.
doi:10.1371/journal.pone.0011515.g002
MD Simulations of APOBEC3G
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structures from NMR and crystallography studies
We next performed 50 ns MD simulations of the A3G C-CDA
high-resolution structures to assess changes from the starting
conformations in a simulated aqueous environment using the
GROMOS force field (see materials and methods). We performed
our analyses on single monomeric C-CDA domains from the
respective studies, which allowed the comparison of the structures
in the absence of crystal packing interactions that may affect the
protein conformations locally. To be able to compare and evaluate
if the solubility-enhancing mutations from the studies by Chen
(NMR1-2K3A), Harjes (NMR3-2K3A) and Shandila (XRAY2-
2K3A) [28,31,32] affected the protein structure during the MD
simulations, we introduced these mutations in silico into the
XRAY1 and NMR2 structures to obtain the XRAY1-2K3A* and
NMR2-2K3A*. Likewise, we restored the wild-type sequence in
NMR1-2K3A, NMR3-2K3A and XRAY2-2K3A, obtaining the
NMR1*, NMR3* and XRAY2* structures (the asterisk indicates
the in silico generated sequences throughout). Simulations were
performed in duplicate, providing a total of 20 A3G C-CDA
structures for subsequent analysis. As duplicate simulations
exhibited equivalent characteristics (Table S1 and Figure S3),
single trajectories for each structure were randomly selected for a
more detailed description. The root mean square deviation
(RMSD) of the C
a atoms of the starting structures over the
simulated time shows that all had reached equilibrium after
approximately 30 ns of the simulation (Figure 4A).
Because of the differences in conformation of b2 in these
structures, the RMSD of the C
a from the residues participating in
the b1-b2 sheet (residues E217-N244) was analysed in more detail
(Figure 4B). Simulations with the crystal structures XRAY1,
XRAY1-2K3A*, XRAY2-2K3A and XRAY2* showed a low
RMSD value of ,1A ˚, demonstrating that the starting confor-
mation of the b2-strand remained stable during the simulations.
This indicates that each of the crystal structures represent
energetically stable conformations of b2. In contrast, simulations
with the NMR structures showed much larger RMSD values of up
to , 3.5 A ˚ for the b2 region, indicating substantial conformational
changes for this part of the molecule. This is furthermore reflected
in an analysis of the root mean square fluctuation (RMSF) of the
residues forming the b1-b2 sheet (Figure 4C), which shows that
NMR1-2K3A, NMR1* and NMR3* have particularly large
fluctuations at residues N236 to F241 that make up the b2 strand.
Together, these results demonstrate that a substantial rearrange-
ment of the residues within b2 occurred during the simulations of
the NMR structures, which have the least structured conforma-
tions of the b2 strand. We note that the structures with the largest
RMSD in the b2 region coincide with those simulations that have
the largest overall RMSD for the whole C-CDA domain
(figures 4A and 4B), suggesting that rearrangement of b2
contributed to the high RMSD values observed.
Secondary structure of the b2 strand during molecular
dynamics simulations
To determine in more detail the conformational changes of the
b2 strand, the stability of the secondary structure elements during
each of the simulations was examined. We did this by plotting
elements of defined secondary structure for each amino acid
against the simulated time (Figure 5, Figure S3 and Figure S4).
This confirmed that the starting conformation of the b2 strand
from the crystal structures remained predominantly stable
throughout the simulations, although temporal closing and
opening of the bulge in the simulations XRAY2-2K3A and
XRAY2* was observed. Simulations with the NMR structures
showed a more dynamical behaviour in the sense that folding of
the b2 strand was generally improved, and in some instances was
periodically disrupted and reformed (Figure 5 and Figure S3). In
particular, the NMR2-2K3A* and NMR3-2K3A simulations
showed the most dramatic stabilization and ordering of the b2-
strand, and NMR2 and NMR3* showed appreciable partial
increases in formation of b2. For NMR1* and NMR1-2K3A we
observed minor increases in formation of b2. These changes in the
b2 region do not appear to influence other secondary structure
elements (Figure S4), indicating that conformational changes
leading to the formation of a more ordered b2-strand are
compatible with the rest of the A3G C-CDA structure.
In order to provide a more quantitative measure for changes in
secondary structure, we calculated the percentage of secondary
structure content for each structure at the beginning and end of
the simulation (table S1). Equivalent proportions of secondary
structure were maintained during the simulations of the crystal
structures. Importantly, all simulations of the NMR structures
showed an increase in b-sheet content with the largest values
observed for NMR2-2K3A* and NMR3-2K3A, in accordance
Figure 3. Alignment of the b1-b2 region from A2 and A3
proteins. Amino acid sequence alignment of the b1-b2 region from
the human A2 and A3 proteins as generated with T-coffee, with the
most conserved residues indicated by grey shading. The positions of b1
and b2 as present in the A2 crystal structure are indicated by arrows
above the alignment. H-bonds between back-bone atoms in the b1-b2
sheet of A2 are indicated with red lines. Purple lines indicate H-bonds
shared by the two crystal structures of the A3G C-CDA domain. The
following H-bonds indicated by purple lines are also present in the NMR
structures: L220-L242 in NMR1-2K3A and NMR3-2K3A; Y222-G240 in all
NMR structures. Green lines indicate H-bonds unique to XRAY1 and
blue lines indicate H-bonds observed in XRAY2-2K3A. Except for the
absence of H-bonds between Y225-L235 in NMR2 and H228-T231 in
NMR3-2K3A, H-bonds indicated by blue lines are also present in the
NMR structures.
doi:10.1371/journal.pone.0011515.g003
MD Simulations of APOBEC3G
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content is mostly attributable to the regularization of b2 of these
NMR structures, as b1, b3, b4 and b5 remained remarkably stable
throughout the simulations (Figure S4).
Hydrogen bonding between b1 and b2
Since the formation of a b-sheet is dependent on the formation
of H-bonds between the two b-strands, we also analysed the
number of H-bonds between the main-chain atoms of the b1-b2
sheet during the simulations (Figure 6). This analysis confirmed
that XRAY1 and XRAY1-2K3A* structures maintain a b1-b2
sheet with a predominantly regular geometry and a minimum of
eight H-bonds that remained stable throughout the simulation
(Figure 6B). Hydrogen bonding also remained stable during the
simulations of XRAY2* and XRAY2-2K3A, and during these
simulations the bulged conformation of b2 was maintained.
Increases in the number of b1-b2 H-bonds from the starting
structure were observed with the NMR1*, NMR2, NMR2-
2K3A*, NMR3* and NMR3-2K3A structures (Figure 6A). Of
these, NMR1* showed the weakest stabilisation of the b1-b2 sheet
by 1 to 2 H-bonds. For the NMR1-2K3A structure there was an
initial loss of H-bonds during the simulation, but in the final stages
this recovered to the same number of H-bonds as present in the
starting structure. Interestingly, during this simulation a different
part of b2 gained in definition at the expense of the defined part of
the b-sheet present in the starting structure (Figure 6C). Together,
these results demonstrate that the A3G C-CDA NMR structures
with a poorly defined b2-strand showed a general tendency
towards the formation of a more stable b1-b2 sheet and this was
observed both in the absence and presence of the five solubility-
enhancing mutations (Figure 6). We note, however, that the most
dramatic stabilisation of b2 was observed with NMR2-2K3A* and
NMR3-2K3A that both contain the solubility enhancing muta-
tions.
We next sought to compare the networks of H-bonds in the
b1-b2 sheet between the different structures. For this purpose
we generated schematic representations of the b1-b2s h e e to n
which the most persistent H-bonds observed during the
simulations are indicated (Figure S5). Comparison of the
starting structures with the MD data revealed that the identity
Figure 4. RMSD and RMSF of the A3G C-CDA Ca atoms from initial coordinates during MD simulations. (A) RMSD of the Ca atoms as
function of time for the whole C-CDA domain and (B) for the b1-b2 region only. Colour code: NMR1* in light green; NMR1-2K3A in pink; NMR2 light
bue; NMR2-2K3A* in orange, NMR3* in cyan; NMR3-2K3A in black; XRAY1 in purple; XRAY1-2K3A* in dark green; XRAY2* in yellow and XRAY2-2K3A
dark blue. (C) RMSF of residues 217–247 with respect to their average position over the entire simulated time; the colour code is the same used (A)
and (B).
doi:10.1371/journal.pone.0011515.g004
MD Simulations of APOBEC3G
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maintained during the simulation, regardless of the presence or
absence of mutations (Figure S5D and E). There was, however,
a tendency to disrupt the H-bonds between T218 and N244 of
the crystal structure XRAY1, which represent the closing H-
bonds of the b1-b2 sheet. Formation of an H-bond between
V224 and R238 was observed in the simulations with XRAY2*
and XRAY2-2K3A, leading to a more closed conformation of
the bulge (Figure S5E). During the simulations of the NMR
structures, the H-bonding pattern was much more dynamic and,
as described above, was generally characterised by an increase
in interactions. This included the formation of novel H-bonds
that were not present in the starting structures of either the
crystal or NMR structures. Interestingly, the simulations with
NMR2 and NMR3* presented stable formation of H-bonds
between residues T218 to Y222 with G240 to N244, which are
also present in both crystal structures (Figure S5B and C). In
fact, the newly formed L220-L242 interaction from NMR2 and
the T218-N244 interaction from NMR3* were among the most
stable throughout the simulations.
Figure 5. Time evolution of the secondary structure elements during MD simulations. Positions of secondary structure elements a1, b1
and b2 are indicated on the y-axis and the simulation time in nanoseconds is indicated on the x-axis. Simulations labelled with an asterisk contain in
silico created mutations. Colours indicate secondary structure elements at a given time point as determined by DSSP classification; a-helices in blue;
b-sheets in red; turns in yellow; bends in green.
doi:10.1371/journal.pone.0011515.g005
MD Simulations of APOBEC3G
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present in the crystal structure XRAY1 was observed during the
simulation with NMR3-2K3A (Figure S5C). In this case, H-
bonds between residues V224, R226 and H228 were formed with
Q237, L235 and V233, respectively, at the expense of the H-
bonds with T231 and V233 that were present in the starting
structure. This rearrangement of H-bonds coincided with
regularisation of the bulge. The simulation with NMR2-2K3A*
demonstrated an alternative regularisation of b2 that was
achieved while maintaining the H-bonding partners of V224,
R226 and H228 (Figure S5B). Thus, our analyses show that the
MD simulations of the NMR structures lead to a better defined
b2 strand, and that there are multiple ways in which this can be
achieved.
Hydration sites in the b1-b2 sheet
We next set out to investigate interactions of the b1-b2 sheet
with the solvent during the A3G C-CDA simulations by means of
MD solvent density analysis [38]. In particular, we analysed the
persistence of water molecules at the b1-b2 region by generating
MD hydration maps (MDHS) for the XRAY1, XRAY2-2K3A,
NMR1-2K3A, NMR2 and NMR3-2K3A structures (Figure 7). In
this type of simulation, the protein structure is restrained to remain
rigid, while allowing the water molecules to reach equilibrium
solvation around the protein [38]. In this manner, sites within the
protein structure that are particularly prone to interact with water
can be identified. Because the protein structure is restrained to
remain rigid, we did not include structures with in silico generated
sequences in this analysis.
Extraction of the MDHS maps from the simulations revealed
that in the NMR structures one to three water molecules are
coordinated within the b1-b2 sheet by the large bulges that are
present in these structures (Figure 7A, B and C). In particular, the
two NMR structures with the largest bulge (NMR1-2K3A and
NMR2, Figure 7A and B) both showed coordination of three
water molecules by the same amino acid residues: Y222, V224 of
the b1-strand and Q237, R238 and G240 of the b2-strand. In the
NMR3-2K3A structure with a smaller b2 bulge, only one water
molecule was observed and this bridges amino acids V224, L235
and Q237 (Figure 7C). In contrast, we did not observe preferential
hydration sites between the two b-strands of the crystal structure
XRAY1 with the continuous b2 strand (Figure 7D), although one
water molecule from the bulk solvent remained in the proximity of
V224 and Q237. Finally, the MDHS analysis performed on
simulations of the XRAY2-2K3A structure predicted the presence
of two persistent water molecules between residues V224 and
L235 (Figure 7E). Importantly, inspection of the electron density
map of the XRAY2-2K3A crystal structure revealed the presence
of two water molecules at precisely this position, thereby validating
our approach (Figure 7F). Together, these results demonstrate that
the presence of a bulged conformation of the b2 strand is driven by
hydration of residues V224, L235 and Q237, and that formation
of an ordered conformation of b2 coincides with the exclusion of
water molecules from the b1-b2 interface.
Figure 6. Structure of the b1-b2 sheet during MD simulations. Number of H-bonds between main-chain atoms of b1 and b2 during the
simulated time. For clarity, data for simulations with NMR and crystal structures are shown in separate plots. Colour coding: (A) NMR1* in light green;
NMR1-2K3A in pink; NMR2 light bue; NMR2-2K3A* in orange, NMR3* in cyan; NMR3-2K3A in black; (B) XRAY1 in purple; XRAY1-2K3A* in dark green;
XRAY2* in yellow and XRAY2-2K3A dark blue. (C) Comparison of the b1-b2 sheet from the starting structures with the most representative structures
derived clustering analysis of the MD simulations for NMR1-2K3A, (D) NMR2 and (E) NMR3-2K3A (F) XRAY1 and (G) XRAY2-2K3A.
doi:10.1371/journal.pone.0011515.g006
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CDA
We next analysed the structures of the C-CDA domain of A3G
to determine whether a DNA binding site near the deaminase
catalytic core could be identified. We already indicated that the
positioning of putative DNA binding grooves and the identifica-
tion of residues that interact with the DNA substrate differs widely
between the crystallography and NMR studies. In particular,
entirely different putative DNA binding grooves were proposed
based on the A3G C-CDA NMR1-2K3A structure and the
XRAY1 crystal structure [34](see the initial structures in Figure 8A
and 8D, respectively). Curiously, the XRAY2-2K3A and NMR3-
2K3A show a surface area with grooves that is similar to XRAY1,
whereas NMR2 most closely resembles the groove proposed for
the NMR1-2K3A structure (Figure 8). Furthermore, the charge
distribution over the surface of the protein is different in each of
the reported structures.
In an attempt to provide some clarity on this important subject,
we sought to assess the integrity of the proposed DNA binding
grooves and the charge distribution over the protein surface during
the MD simulations. For this purpose, we performed a clustering
analysis on each of the MD trajectories to identify the most
populated cluster from which a representative structure could be
derived to compare with the starting structure. Upon selection of
this representative structure, the electrostatic charge distribution
was analysed (Figure 8). We also calculated the solvent accessible
surface areas (SASA) of the protein surface for each of the initial
and representative MD structures to highlight the presence of
grooves or pockets (Figure S6). Together, these sets of data
demonstrate that (1) the putative DNA binding grooves from the
XRAY1, XRAY2-2K3A and NMR1-2K3A structures were not
maintained during the MD simulations, and (2) a wide variety of
possible different pockets or grooves on the surface of the A3G C-
CDA, as well as a diverse charge distribution, were displayed
throughout the MD simulations.
To investigate in some detail the source of these differences, we
generated ribbon models of the C-CDA on which residues R215,
E259 and D316 are indicated (Figure S7). These represent the
three amino acids that were commonly identified as mediating
interactions with the DNA substrate by three different studies
[28–30]. This representation of the intitial and representative MD
structures highlights that there is considerable variability in the
positioning of loops and side chains, which underlies the
aforementioned divergence in exposed surface area and charge
distribution. Indeed, the variable positioning of loops AC1, AC3
and AC7 that largely determine the accessibility of the catalytic
core is evident from a comparison of the starting structures from
the crystallography and NMR studies (Figure 9). These loops
consistently emerged as being the most flexible parts of the A3G
C-CDA throughout our set of MD simulations, as identified by a
principal component analysis (PCA) (Figure 9). The considerable
flexibility of these loops will also have contributed to the relatively
Figure 7. Water binding sites in the b1-b2 sheet as determined by MD solvent density analysis. Water molecules that bridge the
backbone of the b1-b2 sheet are indicated in red and their interactions with amino acid residues are indicated with black dotted lines. The water-
mediated interactions between the backbone of the residues V224 and Y222 in b1 and L235, Q237 and R238 in b2 are shown for: (A) NMR1-2K3A; (B)
NMR2; (C) NMR3-2K3A; (D) XRAY1 and (E) XRAY2-2K3A. (F) Representation of the water molecules observed in the electron density map of the crystal
structure XRAY2-2K3A.
doi:10.1371/journal.pone.0011515.g007
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(Figure 4A). As we did not observe the formation of a common
stable conformation of loops near the catalytic core during MD
simulations, we conclude that there is no evidence to support the
structure of any of the previously proposed DNA binding sites
within the A3G C-CDA domain. This would suggest that DNA
binding to the C-CDA of A3G may instead occur by an induced fit
mechanism. The interaction of A3G with DNA is known to be
dynamic and most likely short-lived as there is ample evidence to
support that A3G can translocate along the DNA to edit multiple
target sites on a single DNA substrate [24,39,40]. This dynamical
behaviour may also underlie the current absence of high resolution
structures of A3G bound to DNA.
Discussion
We have performed a MD study of high-resolution structures of
the A3G C-CDA domain that was prompted by considerable
differences in the integrity of the b2 strand as well as the
organisation and location of a putative nucleic acid binding site. As
three of these structures contained five solubility enhancing
mutations, simulations were performed with and without these
mutations. We confirmed empirically that A3G maintains DNA
editing and virus inhibition activities in the presence of these
mutations.
The b2 strand appears relatively ordered in the crystal structure
XRAY1 but adopts a variety of bulged out conformations in the
NMR structures as well as the second crystal structure XRAY2-
2K3A. Simulations with the crystal structures demonstrated that
the starting conformation of the b2 strand remained stable,
regardless of the presence or absence a bulge interrupting the
strand. On the other hand, a common behaviour for simulations
with NMR structures was observed in the spontaneous formation
of a better ordered and stable b2 strand, as measured in terms of
secondary structure and number of H-bonds involved in the b1-b2
sheet (Figures 5 and 6). We observed a wide range of possible H-
bonding registers within the b1-b2 sheet, which was not limited to
the H-bonds present in the starting structures. Indeed, stabilisation
of the b2 strand was achieved by a variety of H-bonding patterns.
The b2 strand was not universally stabilised in our set of
simulations, and we demonstrated that this is due to differences in
the hydration of residues in the b1-b2 sheet. The presence of a
bulged b2 seems due to a particularly stable hydration site around
residues Y222, V224 of b1 and L235, Q237 and R238 of b2. In
the NMR structures with a bulged b2 strand, these residues
coordinate a different number of water molecules that is
dependent on the extent of the bulge. For instance, the NMR1-
2K3A structure has the most severely disordered b2 strand that
can coordinate three water molecules and showed the least
stabilisation of b2 during the simulations. On the other hand,
simulations with the XRAY1 structure in which the b2 strand
adopts an ordered conformation, we observed that water
molecules were excluded from the b1-b2 sheet.
The conformation of the b2 strand in the A3G C-CDA is of
particular interest because an ordered b2 would allow the
juxtaposition of b-sheets in the N- and C-CDAs of A3G as is
observed in the multimeric crystal structure of the closely related
A2 protein [33]. The formation of an extended b-sheet through
b2-b2 interactions in APOBEC proteins appears to be an
evolutionary conserved feature of these proteins as, in addition
to the A2 crystal structure, there is evidence to suggest that the
AID and A3C proteins are assembled in a similar manner [33,41].
In this regard, it was surprising that several of the A3G C-CDA
structures contained a distorted conformation of b2 that would
disallow the assembly of an elongated b-sheet consisting of the N-
and C-CDA domains. As all available structures of the A3G C-
CDA to date were obtained with constructs from which the N-
CDA was deleted, an exposed b2 strand at the edge of the
structure may not necessarily reflect its presentation or integrity
Figure 8. Charge distribution over the A3G C-CDA surface.
Comparison of the electrostatic surface of the starting structures with
the representative structures from the clustering analysis of the MD
simulations. The potential is ranged from 210kT (red) to +10kT (blue).
(A) NMR1-2K3A; (B) NMR2; (C) NMR3-2K3A; (D) XRAY1 and (E) XRAY2-
2K3A. Dotted lines in (A) and (D) indicate the proposed orientation of
DNA binding grooves.
doi:10.1371/journal.pone.0011515.g008
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have been the cause of the different conformations of b2 observed
in the various structures.
The presence of a predominantly ordered b2 in the XRAY1
crystal structure, as well as the improved definition of b2 during
simulations of the NMR structures, would be consistent with the
assembly of the N- and C-CDA domains into an elongated b-
sheet. However, we recognise that the minimal distortion of b2a s
observed in the crystal structure XRAY1 would still introduce
some deviation from the neatly ordered sheet that is observed in
the structure of A2. This would imply that if the folding of the full-
length A3G protein does proceed by b2-b2 interactions, the
resulting b-sheet may not be as ordered as was previously
predicted based on homology modelling using A2 as a template
[12,16,35](Figure S1). Alternatively, given the diverse array of H-
bond networks within the b1-b2 sheet observed in the starting
structures and during the simulations, it remains possible that the
proximity of the b2 from the N-CDA may induce a specific H-
bonding register. In other words, assembly of the N- and C-CDA
domains via b2-b2 interactions could favour one of the more
ordered conformations of b2, such as those observed in
simulations with NMR2-2K3A* or NMR3-2K3A, over the bulged
conformation. This would also be consistent with our observation
that the bulge is stabilised by bound water molecules, rather than a
stable conformation of the protein backbone itself.
It has been suggested that assembly of a full-length A3G model
through b2-b2 interactions would additionally be prevented by the
inability to link the a6 of the N-CDA to the a1 of the C-CDA
through the residues E191-P199, based on the positioning of a1i n
the NMR3-2K3A structure [31]. In general, definition of a1 in the
NMR studies has not been as good as in the two crystal structures,
which both show that a1 is closely packed against the b-sheet of
the A3G C-CDA (Figure 1) and in a position that would not
restrict the linkage with a6 of the N-CDA (not shown). Together
with our analyses of the structure of the A3G C-CDA domain and
its interactions with the solvent during the molecular dynamics
trajectories this indicates that the possibility of folding the full-
length A3G protein via b2-b2 interactions should not be ruled out.
A definitive positioning of a single stranded DNA binding site
within the A3G C-CDA has also been much debated [28,29,34].
Our analysis of the exposed surfaces for the resolved structures and
the MD simulations thereof further demonstrated the ambiguity in
attempting to identify a pre-defined DNA binding site within the
A3G C-CDA. In addition, we demonstrated that in the absence of
a bound DNA substrate the charged residues involved in the DNA
binding are distributed dynamically over the protein surface. We
showed that differences in positioning of loops AC1, AC3 and
AC7 at present preclude the assignment of a clearly defined DNA
binding pocket within the A3G C-CDA. Loops AC1, AC3 and
AC7 are all in close proximity to the deaminase catalytic core and
contain many of the residues that are thought to contribute to
DNA substrate binding [28–30,42,43]. In particular, these loops
proved the most flexible regions of the molecule during the
simulations (Figure 9). We note that the conformational ambiguity
of b2 may have contributed to confounding the identification of a
DNA binding site. In the primary sequence of the A3G C-CDA,
Figure 9. Conformation of loops near the CDA catalytic core
and their dynamics during the simulations. Ribbon representa-
tions of the A3G C-CDA starting structures (left had column) and
structures after PCA analysis (right hand column) with loops near the
catalytic core highlighted in colour: (A) NMR1-2K3A in green; (B) NMR2
in magenta; (C) NMR3-2K3A in blue; (D) XRAY1 in pink and (E) XRAY2-
2K3A in yellow. Each Ca atom has a cone attached pointing in the
direction of the motion described for the first eigenvector for that atom,
with the size of the cone proportional to the amplitude of motion.
Cones for residues in loops near the catalytic core are shown in blue; all
others are shown in orange. Zinc ions are indicated by grey spheres. In
the XRAY2-2K3A structure a second zinc ion that is remote from the
catalytic core was observed. Plots for simulations with in silico-
generated sequences are not shown.
doi:10.1371/journal.pone.0011515.g009
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between b1 and b2 would thus affect the size and orientation of
this loop.
Binding of DNA at the C-CDA of A3G is known to be
influenced by the N-CDA. In particular, the inclusion of this
domain imparts a higher affinity for the DNA substrate to A3G
than the isolated C-CDA by lowering the dissociation constant
from approximately 400 mM to approximately 50 nM [23,24,28].
In addition, the 39 to 59 directional bias of deamination is only
observed upon inclusion of the N-CDA [15]. It is currently
unknown whether this is due to direct contribution of the N-CDA
to DNA binding or indirectly through structural effects that may
determine the conformations of b2, AC1, AC3 and AC7 of the C-
CDA. The former may potentially be reflected in the inhibitory
effect of RNA binding to A3G on DNA editing [23,39,39], as the
association of A3G with RNA has consistently been attributed to
the N-CDA domain [12,14,16,44]. Thus, fully resolving the
controversy surrounding the interaction of A3G with its substrate
DNA is likely to depend on the inclusion of the N-CDA. In the
absence of such data, our current MD analyses point to
considerable flexibility of loops in the proximity of the catalytic
core, which is most readily reconciled with an induced-fit
mechanism for the binding of single stranded DNA substrate to
the A3G C-CDA.
In this study, we have set out to investigate the differences
between various high-resolution structures of the A3G C-CDA
domain, which are primarily defined by differences in conforma-
tion of the b2 strand and access to the catalytic core. Importantly,
we have shown that ordered conformations of b2 emerged during
MD simulations of the NMR structures that had a disordered
starting conformation of b2. An ordered b2 in the A3G C-CDA
would in turn allow the assembly of the N- and C-CDA domains
into an elongated b-sheet, as is observed in the closely related A2
protein. We have furthermore shown that conflicting reports
concerning the identification of a DNA binding site within the
A3G C-CDA are due to differential positioning and the inherent
flexibility of loops near the deaminase catalytic core. Thus, our
analyses have provided some insight into these much debated
facets of A3G and may inform the unravelling of the interactions
of A3G with its nucleic acid substrates. For example, the precise
mechanism behind the differential target site recognition of
different A3 proteins on DNA substrates and the identity of
specific RNAs that bind to A3 proteins remain poorly understood.
In the absence of an A3G structure bound to substrate, or indeed
the structure of the full-length protein, modelling efforts such as
those presented here provide an alternative method for further
addressing these issues.
Materials and Methods
Molecular Dynamics Simulations
MD simulations were performed with the following structures
from the PDB: 2JYW, 2KBO, 2KEM, 3E1U and 3IR2. The
nomenclature adopted here as well as the original references are
given in table 1. For simulations of structures derived from NMR
studies, the top ranked structure from the deposited bundle,
representing the lowest energy structure, was selected. We also
performed MD simulations of mutant version of these structures,
which were generated in silico using PyMOL (www.pymol.org).
Calculations were performed with the GROMACS package, [45]
using the GROMOS96 force field [46]. Simulations were
performed at pH=7 and the protonation states of pH-sensitive
residues were as follows: Arg and Lys were positively charged, Asp
and Glu were negatively charged, and His was neutral. The net
charge of the protein was neutralized by the addition of Cl
2 and
Na
+ ions. The systems were solvated in a box of
80 A ˚680 A ˚680 A ˚ and SPC water molecules (approximately
16000) were added [47], in a solution of 50 mM NaCl. Periodic
boundary conditions were applied and the Berendsen’s algorithm
[48] for temperature and pressure coupling was adopted (300 K
and 1 atm, respectively). After a first steepest descent energy
minimization with positional restraints on the solute, the LINCS
algorithm was used to constrain the bonds [49] and to carry out an
initial 200 ps simulation with the positions of the solute atoms
restrained by a force constant of 3000 kJ/(mol nm
2) to let the
water diffuse around the molecule and for equilibration. The
particle mesh Ewald method (PME) [50] was used for the
calculation of electrostatic contribution to non bonded interactions
(grid spacing of 0.12 nm) with a cut-off of 1.4 nm and a time step
of 2 fs. The GROMACS package and self-written programs have
been used for the analysis of the data. SASA values were calculated
with the POPS program [51].The MD solvent distribution was
calculated as described previously [38]. The Dynamite Server
(www.biop.ox.ac.uk) was used to produce PCA analysis of the MD
trajectories. Secondary structure analysis was performed with
DSSP [52]. Images were generated with visual molecular
dynamics (VMD 1.8.5.) [53].
Plasmids and cloning
Wild type and mutant A3G expression plasmids for infectivity
studies and the bacterial editing assay were generated as described
previously [12,54].
Single-cycle infectivity assays
Stocks of HIV-1/Dvif [55] were prepared by cotransfection of
35-mm diameter monolayers of 293T cells with 0.5 mg of pA3G
expression vector and 1.0 mg of pIIIB/Dvif using polyethylenimine
(PEI). After 24 hr, the supernatants were harvested and volumes
corresponding to 5 ng p24
Gag used to infect 10
5 TZM-bl indicator
cells. The producer cells were lysed in SDS-containing loading dye
for the analysis of protein expression. The induced expression of b-
galactosidase in whole cell lysates was measured 24 hr after the
initiation of infection using the Galacto-Star system (Applied
Biosystems).
Analysis of protein expression by immunoblotting
Whole cell lysates prepared from virus producing cells were
resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE,
11% gel) and analysed by immunoblotting using primary
antibodies specific for A3G [18] and Hsp90 (sc7947: Santa
Cruz). Blots were resolved using fluorescent secondary antibodies
and the LI-COR infrared imaging technology (LI-COR UK
LTD).
E. coli mutation assay
The KL16 strain of E. coli was transformed with pTrc99A-
based, IPTG-inducible A3G expression vectors or the empty
vector [37]. Individual colonies were picked and grown to
saturation in LB medium containing 100 mg/ml ampicillin and
1 mM IPTG. Appropriate dilutions were spread onto agar plates
containing either 100 mg/ml ampicillin or 100 mg/ml rifampicin
and incubated overnight at 37uC. Mutation frequencies were
recorded as the number of rifampicin-resistant colonies per 10
9
viable cells, which were enumerated using the ampicillin-
containing plates. Colony counts were recorded in this manner
on 12 rifampicin- and 12 ampicilin-containing plates for each
construct, in sets of 4 of each at one time. To average the repeat
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at 100 and all other scores were normalized to this value.
Supporting Information
Figure S1 Implications of the conformation of b2 for the folding
of full-length A3G. View of the extended b-sheet that connects the
N- and C-CDA in a homology model of full-length A3G as a
dimer [12]. Monomer subunits are shown in magenta and green.
The inner N-CDA domains mediate dimerisation of A3G and the
catalytically active C-CDA domains are on the outer part of the
model. In the left-hand monomer subunit of the full-length A3G
homology model (shown in magenta), the structure of the XRAY1
C-CDA is superimposed (shown in blue). (B) Close up of the
proposed b2-b2 interaction in the model of full-length A3G
showing the b1-b2 sheets from the N- and C-CDA in magenta. (C)
The distorted b2 sheet observed in NMR-2K3A is shown in blue
and impedes interaction with b2 of N-CDA model. (D) The
ordered conformation of b2 observed in XRAY1 is shown in blue
and would be consistent with connecting the N- and C-CDA
domains through b2-b2 interactions.
Found at: doi:10.1371/journal.pone.0011515.s001 (1.67 MB
PDF)
Figure S2 Positions of solubility enhancing mutations in A3G-
2K3A. (A) A ribbon model of the NMR1-2K3A structure (PDB
code 2JYW) is shown with the positions of the five solubility
enhancing mutations shown in magenta. The same structure is
shown in (B) after rotation by 180u.
Found at: doi:10.1371/journal.pone.0011515.s002 (0.40 MB
PDF)
Figure S3 Time evolution of the b1-b2 sheet during duplicate
MD simulations. Positions of secondary structure elements a1, b1,
b2 and a2 are indicated on the y-axis and the simulation time in
nanoseconds is indicated on the x-axis. Simulations labelled with
an asterisk contain in silico created mutations. Colours indicate
secondary structure elements at a given time point as determined
by DSSP classification; a-helices in blue; b-sheets in red; turns in
yellow; bends in green. Duplicate simulations are indicated as
MD1 and MD2. Simulations described in detail in the text
correspond to the data from MD1.
Found at: doi:10.1371/journal.pone.0011515.s003 (6.49 MB
PDF)
Figure S4 Time evolution of the secondary structure elements
during MD simulations. Positions of secondary structure elements
a-helices 1 through 6 and, b-strands 1 through 5 are indicated on
the y-axis and the simulation time in nanoseconds is indicated on
the x-axis. Simulations labelled with an asterisk contain in silico
created mutations. Colour indicate secondary structure elements
at a given time point as determined by DSSP classification; a-
helices in blue; b-sheets in red; turns in yellow; bends in green.
Found at: doi:10.1371/journal.pone.0011515.s004 (4.07 MB
PDF)
Figure S5 H-bonding between b1 and b2 in A3G initial
structures and during simulations. Schematic representations of
the b1-b2 sheet with H-bonds between the main-chain atoms
indicated by dotted lines. H-bonds present in the initial structures
are indicated in black. H-bonds observed during the simulations
are colour coded to indicate the life time as a percentage of the
total simulation time: 20%–60% in green, 61% to 80% in blue and
81% to 100% in red. The left column shows the b1–b2 sheet for
the initial structures, the middle column for simulations with the
wild-type sequence and the right column for simulations with the
2K3A mutations. Mutated residues are indicated in red. (A)
NMR1-2K3A, (B) NMR2, (C) NMR3-2K3A, (D) XRAY1 and (E)
XRAY2-2K3A.
Found at: doi:10.1371/journal.pone.0011515.s005 (1.21 MB
PDF)
Figure S6 Exposed surface area of the A3G C-CDA. Compar-
ison of the exposed surface area of starting structures with the
representative structures from the clustering analysis of MD
simulations. Residues indicated in purple have a SASA value
greater than 90 A ˚ 2 and those indicated in green have a SASA
value lower than 40 A ˚ 2. SASA values were calculated with the
POPS program. (A) NMR1-2K3A; (B) NMR2; (C) NMR3-2K3A;
(D) XRAY1 and (E) XRAY2-2K3A.
Found at: doi:10.1371/journal.pone.0011515.s006 (4.89 MB
PDF)
Figure S7 Positioning of amino acids that mediate interactions
of the A3G C-CDA with the DNA substrate. Comparison starting
structures with the most representative structure extracted by
clustering analysis from the MD simulations as ribbon represen-
tations. Amino acid residues R215, E259 and D316 are shown in
stick representations and are indicated with the letters R, E and D,
respectively. These three amino acids represent the agreement
between three independent studies reporting residues within the
A3G C-CDA that mediated interactions with the DNA substrate
[28–30]. The zinc ion at each catalytic core is shown as a grey
sphere. (A) NMR1-2K3A; (B) NMR2; (C) NMR3-2K3A; (D)
XRAY1 and (E) XRAY2-2K3A.
Found at: doi:10.1371/journal.pone.0011515.s007 (3.63 MB
PDF)
Table S1 Percentage of secondary structure in the A3G C-CDA
domain before and after simulations. Secondary structure was
calculated with the DSSP algorithm for the initial and represen-
tative structures from clustering analysis. We performed duplicate
simulations with each structure, which are marked as MD1 and
MD2 in the table. Simulations described in detail in the text
correspond to the data from MD1.
Found at: doi:10.1371/journal.pone.0011515.s008 (0.15 MB
DOC)
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